These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 2684468)

  • 41. [Ten-year experience with the Aldinger custom-made total hip arthroplasty: evaluation of the results].
    Masár J
    Acta Chir Orthop Traumatol Cech; 2007 Jun; 74(3):175-81. PubMed ID: 17623605
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Custom and modular components in primary total hip replacement.
    McCarthy JC; Bono JV; O'Donnell PJ
    Clin Orthop Relat Res; 1997 Nov; (344):162-71. PubMed ID: 9372768
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical experience with a custom-made hip prosthesis developed in Norway].
    Svenningsen S
    Tidsskr Nor Laegeforen; 2007 Feb; 127(4):432-4. PubMed ID: 17304270
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The rationale, design characteristics, and preliminary results of a primary custom total hip prosthesis.
    Stulberg SD; Stulberg BN; Wixson RL
    Clin Orthop Relat Res; 1989 Dec; (249):79-96. PubMed ID: 2684468
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Design, production and clinical application of custom total hip prosthesis].
    Jiang T; Liu J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Apr; 22(2):392-5. PubMed ID: 15884563
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The rationale for cementless revision total hip replacement with contemporary technology.
    Gorab RS; Covino BM; Borden LS
    Orthop Clin North Am; 1993 Oct; 24(4):627-33. PubMed ID: 8414428
    [TBL] [Abstract][Full Text] [Related]  

  • 47.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 48.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 49.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.